Muni problems? What muni problems?
Their tax-exempt status is threatened, and the situation Detroit isn’t helping, but you wouldn’t know it from the brisk business at BondDesk.
The retail platform for municipal bond trading reported an all-time record of 11,590 municipal bond trades were done on Monday on the BondDesk ATS.
The record came on the heels of the largest three-day increase in yields since April 1987 and in the wake of last week’s Federal Reserve meeting.
John Bagley, president of BondDesk Trading, noted that interest in municipal bonds from retail investors has spiked over the past week along with the increase in yields.
“The municipal bond market has seen exceptionally large selling from institutions since the Fed meeting last Wednesday,” Bagley said in a statement. “This week, individual investors provided support for the market and drove yields down across the board by buying bonds at unprecedented levels. This buying was driven by an ability to buy 5.00% coupon bonds at par on a wide variety of quality municipal credits.”
Top 5 Consumer Stocks To Watch Right Now: United Parcel Service Inc.(UPS)
United Parcel Service, Inc., a package delivery company, provides transportation, logistics, and financial services in the United States and internationally. It operates in three segments: U.S. Domestic Package, International Package, and Supply Chain & Freight. The U.S. Domestic Package segment engages in the time-definite delivery of letters, documents, and packages in the United States. The International Package segment offers air and ground delivery of small packages and letters to approximately 220 countries and territories, including shipments outside the United States, as well as shipments with either origin or distribution outside the United States; export services; and domestic services move shipments within a country?s borders. The Supply Chain & Freight segment provides forwarding and logistics services, such as supply chain design and management, freight distribution, customs brokerage, mail, and consulting services in approximately 195 countries and territorie s; and less-than-truckload and truckload services to customers in North America. In addition, the company offers various technology solutions for automated shipping, visibility, and billing; information technology systems and distribution facilities to various industries comprising healthcare, technology, and consumer/retail; and a portfolio of financial services that provides customers with short-term working capital, government guaranteed lending, global trade financing, credit cards, and export financing. It operates a fleet of approximately 99,800 package cars, vans, tractors, and motorcycles; an air fleet of 527 aircraft; and 33,800 containers used to transport cargo in its aircraft. The company was founded in 1907 and is headquartered in Atlanta, Georgia.
Advisors' Opinion:- [By Jason Moser]
Getting stuff from point A to point B has been going on for a long time; there's nothing really new to the concept here. Global shipping goliath United Parcel Service (NYSE: UPS ) has been doing a bang-up job of it for years -- since 1907, in fact, when the company was founded. Today, it's the world's largest package delivery company and in 2012 it was responsible for delivering 4.1 billion packages (16.3 million pieces per day) and brought in more than $54 billion in sales.
- [By Tim Brugger]
In what UPS (NYSE: UPS ) CEO Scott Davis calls "a win-win-win for our people, customers, and shareholders," the company has reached a "tentative agreement" with nearly 250,000 Teamsters Union employees on two five-year contracts. The first deal addresses union employees in UPS' packaging unit; the other agreement impacts freight employees, the sides recently announced.
- [By Chuck Saletta]
Speaking of results ...
United Technologies (NYSE: UTX ) reported decent numbers, with net earnings ahead of expectations but growth driven more by acquisitions than by organic improvements in its existing businesses. Given the company's conglomerate setup, growth by bolt-on acquisitions isn't surprising, but over the long haul, it'd be better to see its businesses growing internally as well as through acquisitions. The news at Mine Safety Appliances (NYSE: MSA ) wasn't quite as good, with both revenues and net earnings falling from year ago levels on a tough environment for the mining businesses it supports. That's a risk well known to the company and its shareholders, though, and while the weaker results did knock the company's stock down, the business has ridden through tough cycles before. It looks capable of riding through this one, too. Hasbro (NASDAQ: HAS ) , on the other hand, reported earnings that beat expectations on an operating basis, before restructuring charges knocked it down to a net loss. Given that the company is in the very seasonal toy business, that loss in an off-peak quarter is much less of a concern than it would have been in the make-or-break holiday quarter. UPS (NYSE: UPS ) kept on trucking, with a better-than-expected January and strength from eCommerce helping the company turn in an 8% growth in net reported earnings per share. Overall, UPS is operating efficiently, though its future success is tied to its ability to continue delivering more packages. As long as its e-commerce business continues to grow, though, UPS is wel
Right now, quarterly earnings season is well under way, which provides a perfect opportunity for one of those "check in from time to time" moments. While the iPIG portfolio did nothing last week, several of its picks did report, and those quarterly confessionals can help determine whether the companies are still worth owning. To summarize key results: - [By Paul Ausick]
Big Earnings Movers: Amazon.com Inc. (NASDAQ: AMZN) is up 9.5% at $363.67 after last night�� results. Microsoft Corp. (NASDAQ: MSFT) is up 6% at $35.73 on good gains in consumer and device sales. Zynga Inc. (NASDAQ: ZNGA) is up 5.5% at $3.73 on a smaller-than-expected loss. The Procter & Gamble Co. (NYSE: PG) is down 0.8% at $79.98 following inline earnings that encouraged investors to take profits. United Parcel Service Inc. (NYSE: UPS) is up 1.2% at $95.62 after good earnings led to a new 52-week high of $97.00.
Top 10 Quality Companies To Buy For 2014: Euro FX(P)
Ecopetrol S.A. operates as an integrated oil company in Colombia, Peru, Brazil, and the U.S. Gulf Coast. The company engages in the exploration, development, and production of crude oil and natural gas. As of December 31, 2010, its proved reserves of crude oil and natural gas consisted of 1,714.0 million barrels of oil equivalent. The company also transports crude oil, motor fuels, fuel oil, and other refined products, as well as mixture of diesel and palm oil. It owns transportation network consisting of 3,003 kilometers of crude oil pipeline directly, as well as an additional 2,178 kilometers of crude oil pipeline with its business partners; and 3,017 kilometers of multi-purpose pipelines for transportation of refined products from refinery to wholesale distribution points. As of the above date, Ecopetrol S.A. owned 58 stations with a nominal storage capacity of 19 million barrels of crude oil and 6 million barrels of refined products. In addition, the company owns and o perates refineries that produce a range of refined products, including gasoline, diesel, kerosene, jet fuel, aviation fuel, liquefied petroleum gas, sulfur, heavy fuel oils, motor fuels, and petrochemicals, including paraffin waxes, lube base oils, low-density polyethylene, aromatics, asphalts, alkylates, cyclohexane and aliphatic solvents, and refinery grade propylene, as well as provides industrial services to third parties. Further, it markets various refined and feed stock products, including regular and high octane gasoline, diesel fuel, jet fuel, natural gas, and petrochemical products. The company was formerly known as Empresa Colombiana de Petroleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was founded in 1948 and is based in Bogota, Colombia.
Advisors' Opinion:- [By Ben Eisen]
Pandora Media Inc. (P) �plunged 17% after reporting better-than-expected revenues and a narrower first-quarter loss late Thursday, but a disappointing outlook. The Internet-radio company said it expected to earn between zero and 3 cents a share in the second quarter on revenue that ranges between $213 million and $218 million. That was below analyst forecasts of 5 cents a share in profit on sales of $218 million.
- [By Alex Planes]
What: Shares of Pandora Media (NYSE: P ) have fallen 11% today after news that a certain digital-music pioneer is making big moves in the streaming space.
Top 10 Quality Companies To Buy For 2014: Penn Virginia Corporation(PVA)
Penn Virginia Corporation, an independent oil and gas company, primarily engages in the exploration and development of natural gas and oil properties in various onshore regions of the United States. The company is involved in the production and sale of natural gas, crude oil, and natural gas liquid products. It primarily focuses on developing the Eagle Ford Shale play in south Texas; and the horizontal Granite Wash play in the Mid-Continent region. The company also drills exploratory wells in the Marcellus Shale play in Pennsylvania; and has interests in the natural gas properties in the Haynesville Shale and Cotton Valley Sands in east Texas, and Selma Chalk in Mississippi. As of December 31, 2011, it had proved natural gas and oil reserves of approximately 883 billion cubic feet of natural gas equivalent; and owned approximately 1.1 million net acres of leasehold and royalty interests. The company sells its products using short-term floating price physical and spot marke t contracts. Penn Virginia Corporation was founded in 1882 and is headquartered in Radnor, Pennsylvania.
Advisors' Opinion:- [By Sally Jones] ng>Yield: 16.40%
Up 99% over 12 months, Penn Virginia Corporation, an independent oil and gas E&P company, has a market cap of $600.69 million; its shares were traded at around $9.20. Shares trade with a P/B of 0.67.
Guru Action: As of the second quarter of 2013, George Soros holds 1,878,242 shares valued at around $8.82 million.
PVA is a new buy for Soros who last sold out in the first quarter of 2010, selling 9,700 shares at an average price of $24.89, for a loss of 63%.
In the second quarter of 2013, Soros made a gain of 108.6% on his new buy of 1,878,242 shares at an average price of $4.41.
Over his trading history, he has averaged a gain of 109% on 1,878,242 shares bought at an average price of $4.41
Track historical pricing, revenue and net income:
[ Enlarge Image ]
Macquarie Infrastructure Company LLC (MIC)
Yield: 5.33%
Up 26% over 12 months, Macquarie Infrastructure Company LLC, an industrial distribution company, has a market cap of $2.95 billion; its shares were traded at around $55.13. Shares trade with a P/E of 641.00.
Guru Action: As of the second quarter of 2013, George Soros holds 25,000 shares valued at around $1.33 million.
In the second quarter, he reduced his position by 13.76%, selling 3,989 shares at an average price of $54.9, for a gain of 0.4%.
In six quarters he has bought 28,989 shares at an average price of $49.71, for a gain of 11%. He gained 0% selling 3,989 shares at an average price of $54.9.
Track historical pricing, revenue and net income:
[ Enlarge Image ]
STMicroelectronics NV (STM)
Yield: 4.67%
Up 28% over 12 months, STMicroelectronics NV, a semiconductor company, has a market cap of $6.77 billion; its shares were traded at around $7.60. Shares trade with a P/B of 1.20.
Guru Action: As of the second quarter of 2013, George Soros holds 1,766,666 shares valued at around $15.88 million.
STM is a new hold
Top 10 Quality Companies To Buy For 2014: Viad Corp(VVI)
Viad Corp, together with its subsidiaries, operates in exhibition and events, and travel and recreation industries primarily in North America, the United Kingdom, Germany, and the United Arab Emirates. The company?s Marketing & Events Group segment designs, plans, and produces face-to-face events for show organizers, corporate brand marketers, and retail shopping centers. It offers general event management, planning and consultation, concept design, exhibition layout and design, graphics and design, show traffic analysis, carpeting and flooring, decorating products and accessories, custom graphics, overhead rigging, and cleaning services, as well as temporary electrical, lighting, and plumbing services. This segment also provides custom exhibit design and construction; portable and modular exhibits and design; integrated marketing, including pre- and post-event communications and customer relationship management; multimedia services; event surveys; return on investment an alysis; attendee and exhibit booth traffic analysis; staff training; online management tools; logistics and freight-forwarding, storage, and refurbishment of exhibits; booth furnishings, carpeting, and signage; in-house installation and dismantling; and various other show services. In addition, the segment offers various entertaining attractions and brand-based experiences, sponsored events, mobile marketing and other branded entertainment, and face-to-face marketing solutions for clients and venues, including movie studios, leading consumer brand marketers, shopping malls, museums, and casinos. Its Travel & Recreation Group segment provides tourism products, including attractions, transportation services, inbound package tour operations, hotel operations, and corporate and event management; operates five lodges, three motor inns, and one resort hotel; and engages in food and beverages, and retail and concession businesses. Viad Corp was founded in 1914 and is headquartered in Phoenix, Arizona.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Viad Corp (NYSE: VVI ) , whose recent revenue and earnings are plotted below.
Top 10 Quality Companies To Buy For 2014: Edp Energias de Portugal SA (EDPFY.PK)
EDP Energias de Portugal SA (EDP), incorporated in 1976, is a Portugal-based company engaged in the electric energy and gas sectors. The Company develops its activities in the business areas of generation, supply and distribution of electricity and supply and distribution of gas. The Company operates through six business units: Electricity Generation, Renewable Energies, Electricity Distribution, Electricity Supply, Gas and Brazil Operations. EDP is also present in electricity generation, supply and distribution in Brazil, Spain and the United States. In April 2008, the Company acquired EDP Renovaveis through Nuevas Energias de Occidente (NEO). In February 2008, Horizon Wind Energy, LLC, EDP�� 100%-owned subsidiary for United States wind operations, acquired from Hydra Energy, LLC, a portfolio of six early stage projects in an aggregate of 1,050 megawatts of wind capacity, located in the States of Illinois, Indiana and Ohio, the United States.
Electricity Generation
In Spain, EDP operates through HC Energia. Cogeneration consists of simultaneous production of power and steam using thermal technology, such as in the form of natural gas turbines. Cogenerators are usually attached to an industrial customer or services, to which they supply the electricity and steam they need. Energy generation includes a centralised energy management platform responsible for actively managing the price and volume risks for the EDP Company�� portfolio in the Iberian Peninsula.
Renewable Energies
The Company�� electricity from renewable energies is generated by its subsidiary NEO, and in the United States of America by its subsidiary Horizon Wind Energy. In July 2007, EDP acquired 100% interest in Horizon, a developer, owner and operator of wind power generation in the United States, from the Goldman Sachs Group, Inc. In September 2007, Horizon owned 941 gross megawatt of operating wind projects and has 615 megawatt of projects under construction, for expected operational ! capacity of 1.556 gross megawatts (1.324 net megawatts).
Electricity Distribution
EDP develops the regulated electricity distribution activity in mainland Portugal and in Spain in the Asturias region and to a lower extent in Madrid, Valencia and Alicante. Electricity distribution activity is a regulated activity that consists in bringing the electricity, through the distribution network, from the transport network substations to the final consumption points. Within the scope of this activity, EDP builds, operates and maintains the distribution network and other installments aimed at electricity distribution, granting service quality and direct and customized assistance.
EDP Distribuicao Energia, S.A. is EDP�� company operating in the regulated distribution and supply businesses in Portugal. EDP�� distribution activity is regulated by energy service regulator (ERSE), which defines the tariffs, parameters and prices for electricity and other services in Portugal, controlling and assuring the levels of quality and service demanded by the Direccao Geral de Geologia e Energia (DGGE). EDP Distribuicao is holder of an open-ended binding license for the business of distribution of medium- and high-voltage electricity in mainland Portugal. It is also the concessionaire for almost all the low-voltage distribution network, in accordance with concession contracts with the municipalities. HC Energia operates in the regulated electricity distribution and supply business, with its natural market being the region of Asturias. HC Energia�� network covers the Asturias, Valencia, Madrid and Alicante regions.
Electricity Supply
EDP's electricity supply offers the services, such as maintenance and assistance services, services aimed at electricity quality, specialized technical services and energy efficiency services. EDP operates in Portugal through EDP Comercial, while in Spain, its electricity supply service is obtained from HC Energia or Naturgas, ! which off! ers its customers an integrated portfolio of gas and electricity products.
Gas
EDP has a presence in the gas sector in the Iberian Peninsula, through Naturgas in Spain, and through EDP Gas in Portugal. Naturgas market is the Basque Country, and Asturias, and it operates in the Spanish gas sector by providing services, such as transport, distribution and supply of gas; supply of gas in the liberalized market, and sourcing and trading.
Brazil Operations
EDP is present in Brazil through Energias do Brasil, a 62.4%-owned subsidiary. Energias do Brasil operates in the electricity generation, distribution and supply businesses.
Advisors' Opinion:- [By David Hunkar]
Current Dividend Yield: 6.43%
Company: Edp Energias De Portugal SA (EDPFY.PK)
Sector: Telecom
Country: AustraliaCurrent Dividend Yield: 4.68%
Sector: Electric Utilities
Country: Portugal
Top 10 Quality Companies To Buy For 2014: Novartis AG (NVS)
Novartis AG, incorporated on February 29, 1996, provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The Company has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. On April 8, 2011, the Company acquired the remaining non-controlling interest in Alcon, Inc. In December 2013, Alliance Pharma plc announced that its wholly owned subsidiary, Alliance Pharmaceuticals Limited, acquired all the United Kingdom and Republic of Ireland (ROI) rights to Lypsyl from Novartis AG.
In April 2011, Novartis sells global rights to Elidel, a medicine to treat atopic dermatitis to Meda. In March 2011, Novartis completes acquisition of majority stake in Zhejiang Tianyuan vaccines company in China. In March 2011, the Company acquired Genoptix, Inc. In October 2011, Novartis discontinues development of AGO178 for depressive disorder. In December 2011, the Company discontinues development of PRT128 for acute coronary syndrome and chronic coronary heart disease, and SMC021 for osteoporosis and osteoarthritis. In April 2011, Alcon's portfolio of generic ophthalmic medicines sold through its Falcon business unit primarily in the United States.
Pharmaceuticals Division
The Company�� Pharmaceuticals Division researches, develops, manufactures, distributes and sells patented prescription medicines in the therapeutic areas, such as Oncol! ogy; Primary Care, consisting of Primary Care medicines and Established Medicines, and Specialty Care, consisting of Ophthalmology, Neuroscience, Integrated Hospital Care, and Critical Care medicines. The Pharmaceuticals Division is organized into global business franchises responsible for the commercialization of various products, as well as Novartis Oncology, a business unit responsible for the global development and commercialization of oncology products, and Novartis Molecular Diagnostics, a business responsible for the development and commercialization of diagnostic tests and services related to its pharmaceuticals portfolio and therapeutic areas.
The Company�� Oncology products include Afinitor/Votubia, Exjade, Sandostatin SC/Sandostatin LAR , Femara , Zometa, Tasigna and Gleevec/Glivec. Gleevec/Glivec, which is a signal transduction inhibitor approved to treat patients with certain forms of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Tasigna is a signal transduction inhibitor of the tyrosine kinase activity of Bcr-Abl, KIT+ and the PDGF-receptor. Zometa is a treatment to reduce or delay skeletal-related events (SREs), including pathologic fracture, spinal cord compression, and/or requirement of radiation therapy or surgery to bone, in patients with bone metastases (cancer that has spread to the bones) from solid tumors and multiple myeloma. Femara is a once-daily oral aromatase inhibitor for the treatment of early stage or advanced breast cancer in postmenopausal women. Sandostatin SC/Sandostatin LAR is indicated for the treatment of patients with acromegaly, a chronic disease caused by over-secretion of pituitary growth hormone in adults. Sandostatin is also indicated for the treatment of patients with certain symptoms associated with carcinoid tumors and other types of gastrointestinal and pancreatic neuroendocrine tumors. Exjade is an oral iron chelator approved for the treatment of chronic iron overload due to blood transfusions in patients over ! two years! of age who have a range of underlying anemias. Patients with congenital and acquired chronic anemia, such as thalassemia, sickle cell disease and myelodysplastic syndromes, require transfusions, which puts them at risk of iron overload. Afinitor/Votubia is an oral inhibitor of the mTOR pathway.
The Company�� Primary Care products include Arcapta Neohaler/Onbrez Breezhaler, Diovan, Exforge, Tekturna/Rasilez, Galvus, Reclast/Aclasta, Voltaren/Cataflam, Ritalin, Ritalin LA, Focalin and Focalin XR. Its Specialty Care products include Lucentis, Gilenya, Exelon, Extavia and Comtan, and Stalevo. Its Integrated Hospital Care include Zortress/Certican, Ilaris, Neoral and Myfortic.The Company�� Critical Care products include Xolair and Tobi Podhaler. As of December 31, 2011, the products under development includes ACZ885, which is being investigated for the secondary prevention of cardiovascular events and for the treatment of Diabetes Mellitus; AEB071 (sotrastaurin) is a low molecular weight, selective inhibitor of protein kinase-C (PKC); AFQ056 (mavoglurant) is a metabotropic glutamate receptor 5 (mGluR5) antagonist in Phase II development for the treatment of Parkinson's disease levodopa-induced dyskinesia; AIN457 (secukinumab) is a human monoclonal antibody neutralizing interleukin-17A, a key pro-inflammatory cytokine expressed by TH17 cells and other types of white blood cells; BAF312 is an oral, second-generation sphingosine 1-phosphate receptor modulator in Phase II development for relapsing-remitting multiple sclerosis; DEB025 (alisporivir) is a cyclophilin inhibitor for the treatment of Hepatitis C virus infection (HCV); Gileny a line treatment for relapsing forms of MS; Exjade (deferasirox) is an oral iron chelator in development for use in patients with non-transfusion-dependent thalassemia (NTDT); INC424 (ruxolitinib) is an investigational Janus kinase (JAK) inhibitor, and Zortress/Certican (everolimus) is an mTOR inhibitor with immune/non-immune cell proliferation inhibition being d! eveloped ! for prevention of solid organ transplant rejection.
Alcon Division
The Company�� Alcon Division discovers, develops, manufactures, distributes and sells eye care products. Alcon is engaged in eye care with product offerings in Surgical, Ophthalmic Pharmaceuticals and Vision Care. In Surgical, Alcon develops, manufactures, distributes and sells ophthalmic surgical equipment, instruments, disposable products and intraocular lenses. In Pharmaceutical, Alcon discovers, develops, manufactures, distributes and sells medicines to treat chronic and acute diseases of the eye, as well as over-the-counter medicines for the eye. In Vision Care, Alcon develops, manufactures, distributes and sells contact lenses and lens care products.
Alcon's Surgical portfolio includes the Infiniti vision system for cataract procedures, the Constellation vision system for retinal operations, and the AcrySof family of intraocular lenses (IOLs), including the AcrySof IQ, AcrySof IQ ReSTOR, AcrySof IQ Toric and AcrySof IQ ReSTOR Toric IOLs. During the year ended December 31, 2011, its Alcon Division launched the LenSx femtosecond laser, a technology in cataract surgery, which increases the precision and reproductibility for corneal incisions, capsulorhexis and lens fragmentation steps of the procedure. In addition, Alcon provides advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery.
Alcon Division's Ophthalmic Pharmaceuticals business combines Alcon's range of pharmaceuticals with selected ophthalmic products (excluding Lucentis) previously marketed by the Novartis Pharmaceuticals Division. The products treat chronic and acute diseases of the eye including glaucoma and allergies, as well as anti-infective/anti-inflammatory and dry eye treatments. our Alcon Division's Ophthalmic Pharmaceuticals portfolio include Travatan Z solution and DuoTrav solution for the treatment of elevated intraocular pressure associ! ated with! glaucoma; Vigamox solution for bacterial conjunctivitis; Pataday solution for ocular itching associated with allergic conjunctivitis; and Nevanac suspension for eye inflammation following cataract surgery. Alcon launched a number of products during 2011, including Dailies Total 1 lenses, Opti-Free EverMoist Multi Purpose Disinfecting Solution, LenSx laser, AcrySof IQ ReSTOR Toric lens, AcrySof IQ Toric T6-T9 lens, Travatan BAK-free solution, DuoTrav BAK-free solution, Moxeza solution and Systane Balance eye drops.
Sandoz Division
The Company�� Sandoz Division is a global generic pharmaceuticals company that develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical and biotechnological active substances, which are not protected by valid and enforceable third-party patents. The Sandoz Division has activities in Retail Generics, Anti-Infectives, and Biopharmaceuticals and Oncology Injectables. In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of pharmaceuticals, as well as supplying active ingredients to third parties. In Anti-Infectives, Sandoz develops and manufactures active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by retail generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products (biosimilars or follow-on biologics) and sells biotech manufacturing services to other companies.
In Oncology Injectables, Sandoz develops, manufactures and markets primarily cytotoxic products for the hospital market. During 2011, the Company launched generic docetaxel (Taxotere), higher-strength generic amlodipine-benazepril (Lotrel), generic meropenem (Merem) injection, and the formation of a women's health portfolio with generic Seasonale, Nordette, Yaz and Yasmin. The product launched in various European countries included generic docetaxel, ge! neric ana! strazole (Arimidex), and valsartan/covalsartan (an early entry generic version of Novartis Pharmaceuticals' Diovan/Co-Diovan).
Vaccines and Diagnostics Division
The Company�� Vaccines and Diagnostics Division researches, develops, manufactures, distributes and sells preventive vaccines and diagnostic tools. Novartis Vaccines is a global developer and manufacturer of human vaccines. Novartis Diagnostics is a blood testing and molecular diagnostics business dedicated to preventing the spread of infectious diseases through blood-screening tools that protect the world's blood supply. Novartis Vaccines' products include influenza, meningococcal, pediatric, adult and travel vaccines.
The Company�� influenza vaccines include Agrippal, Fluad, Fluvirin and Optaflu. Its Meningococcal Vaccines includes Menjugate and Menveo. Its travel vaccines include Encepur Children, Encepur Adults, Ixiaro and Rabipur/Rabavert. Its Pediatric Vaccines include Polioral and Quinvaxem.
Consumer Health
Consumer Health consists of two Divisions: OTC (over-the-counter medicines) and Animal Health. Each has its own research, development, manufacturing, distribution and selling capabilities. OTC offers readily available consumer medicine. Animal Health provides veterinary products for farm and companion animals.
OTC (over-the-counter medicines) offers products for the treatment and prevention of common medical conditions and ailments. OTC business focuses on a group of global brands in product categories that include treatments for cough/cold/respiratory (Triaminic, Otrivin, TheraFlu/NeoCitran), pain relief (Excedrin, Voltaren), digestive health (Benefiber, Prevacid24HR, Pantoloc Control), dermatology (Lamisil, Fenistil), and smoking cessation (Habitrol/Nicotinell).
Animal Health offers products and services focusing on both companion and farm animals (including cultivated fish). Key products for companion animals include Atopica (atopic dermatitis manageme! nt), Dera! maxx and Onsior (pain relief), Fortekor (heart failure in dogs, chronic renal insufficiency in cats), and Sentinel/Milbemax/Interceptor (intestinal parasite control and heartworm prevention), while farm animal products include the therapeutic anti-infective Denagard, an antimicrobial used to treat and control bacteria in swine, CLiK, an insect growth regulator used to control blowfly strike in sheep, cattle vaccines used to prevent respiratory and reproductive diseases in beef and dairy cattle, and Zolvix, a sheep drench representing the new sheep anthelmintic class. Aquaculture products include vaccines and treatments mainly used in salmon farming.
Advisors' Opinion:- [By Brian Pacampara]
So what: The trial showed that patients taking the once-daily drug Arikace had a smaller improvement in lung capacity than those treated with Novartis' (NYSE: NVS ) twice-daily competitor TOBI, triggering plenty of investor concern over Arikace's position in the market. While Insmed said that the trial met its main objective of showing that Arikace was not statistically inferior to TOBI, the lackluster results -- it isn't exactly superior -- suggest that the drug's sales potential is limited.
- [By Jayson Derrick]
Novartis (NYSE: NVS) unit Alcon received the rights to license Google's (NASDAQ: GOOG) smart lens technology for ocular medical uses and create a "smart contact lens." Shares of Novartis lost 0.12 percent, closing at $90.14 while shares of Google lost 0.02 percent, closing at $584.78.
- [By Jeff Reeves]
Another option is the iShares Europe ETF (IEV). It owns BP (BP) and pharmaceutical powerhouse Novartis (NVS). Both this ETF and the Vanguard fund have nearly all their assets invested in European stocks.
Top 10 Quality Companies To Buy For 2014: Heidelberger Druckmaschinen AG (HDD)
Heidelberger Druckmaschinen AG is a German producer of solutions for the print media industry. The Company divides its activities into the three business segments Heidelberg Equipment, Heidelberg Services as well as Heidelberg Financial Services. Its product portfolio includes the prepress area with the Suprasetter product family; the press area, which comprises Speedmaster product families, that are used for classical offset printing, as well as for special applications, such as ultraviolet (UV) printing; as well as the postpress area, that includes cutters, folders, saddle stitchers, adhesive binders, die-cutting products, folding carton gluing machines and label systems. The Company also offers a range of spare parts and used equipment, as well as training programs and its own printing process automation software, Prinect. As of December 31, 2011, the Company operated three domestic subsidiaries and a number of foreign subsidiaries in Europe, Africa, Asia and Brazil, among others. Advisors' Opinion:- [By Nicolas73]
Seagate Technology (STX) is a company involved in the design, manufacture, marketing and selling of Hard Disk Drives (HDD).
They produce HDDs for enterprise applications (e.g. enterprise servers), client compute applications (mainly for notebooks), and non-compute applications (e.g. portable devices).
No comments:
Post a Comment